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AbstrACt
Objectives To report the situation of maternal 
micronutrient supplementation before and during 
pregnancy in Northwest China and to examine the rates 
of and factors related to the adherence to micronutrient 
supplementation among pregnant women in this 
region, where dietary micronutrient intake is commonly 
insufficient.
Design A large-scale population-based cross-sectional 
survey.
setting Twenty counties and ten districts of Shaanxi 
Province.
Participants A sample of 30 027 women were selected 
using a stratified multistage random sampling method. A 
total of 28 678 women were chosen for the final analysis 
after excluding those who did not provide clear information 
about nutritional supplementation before and during 
pregnancy.
Main outcome measures Maternal adherence to 
micronutrient supplementation (high and low) were the 
outcomes. They were determined by the start time and 
duration of use according to Chinese guidelines (for 
folic acid (FA) supplements) and WHO recommendations 
(for iron, calcium and multiple-micronutrient (MMN) 
supplements).
results In total, 83.9% of women took at least one kind 
of micronutrient supplement before or during pregnancy. 
FA (67.6%) and calcium (57.5%) were the primarily used 
micronutrient supplements; few participants used MMN 
(14.0%) or iron (5.4%). Adherence to supplementation 
of all micronutrients was low (7.4% for FA, 0.6% for 
iron, 11.7% for calcium and 2.7% for MMN). Higher 
educational levels, higher income levels, urban 
residence and better antenatal care (including pregnancy 
consultation and a higher frequency of antenatal visits) 
were associated with high adherence to micronutrient 
supplementation.
Conclusion Maternal micronutrient supplementation 
before and during pregnancy in Northwest China was way 
below standards recommended by the Chinese guidelines 
or WHO. Targeted health education and future nutritional 
guidelines are suggested to improve this situation, 
especially in pregnant women with disadvantaged 
sociodemographic conditions.
IntrODuCtIOn
Pregnancy is a state in which macronutrient 
and micronutrient requirements increase 
due to maternal physiological changes and 
fetal growth.1 During pregnancy, adequate 
micronutrient intake is difficult to achieve 
from daily diet,2 and maternal micronu-
trient deficiencies could cause severe adverse 
outcomes, including stillbirth, low birth 
weight (LBW) and birth defects.3 Micro-
nutrient supplementation is an alterna-
tive, in addition to the adjustment of diet 
pattern and quality, to fulfil the increased 
nutrition demands during pregnancy.4 In 
recent decades, maternal micronutrient 
strengths and limitations of this study
 ► This is the first large-scale and representative study 
that vividly described maternal adherence to micro-
nutrient supplementation before and during preg-
nancy in Northwest China.
 ► Sample representativeness in Shaanxi was guaran-
teed by a large sample of 28 678 women that were 
recruited using a stratified multistage random sam-
pling method.
 ► The results could be generalised in Northwest China 
and may also reflect the universality of the problem 
in China and could serve as a basis for developing 
health education strategies in the future.
 ► Recall bias was ineluctable because the information 
was self-reported by retrospection.
 ► The study does not provide an insight into the dos-
age of specific micronutrient supplementation due 
to the uncertain specifications of some reported 
supplements.
Protected by copyright.
 o
n
 12 August 2019 at Liverpool School of Tropical M
edicine.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-028843 on 8 August 2019. Downloaded from 
2 Liu D, et al. BMJ Open 2019;9:e028843. doi:10.1136/bmjopen-2018-028843
Open access 
supplementation during pregnancy has attracted much 
attention, as growing evidence has shown that it has 
significant benefits in the improvement of maternal 
health status as well as birth outcomes.5–8 As a result, 
some micronutrients that greatly contribute to maternal 
and fetal health are highly recommended for routine use 
during pregnancy. Many countries have implemented 
periconceptional folic acid (FA) supplementation to 
protect against neural tube defects (NTDs).9 10 WHO 
has also provided several guidelines for micronutrient 
supplementation for pregnant women.11 Daily use of 
FA (400 µg), starting from 2 months before the planned 
pregnancy to 12 weeks of pregnancy, is recommended 
for the prevention of NTDs;12 daily oral FA combined 
with iron supplementation (400 µg FA and 30–60 mg 
iron) throughout pregnancy is recommended to reduce 
the risk of LBW, maternal anaemia and iron deficiency;13 
daily oral calcium supplementation (1.5–2.0 g) in the 
second half of pregnancy is recommended for preg-
nant women in the area of low dietary calcium intake to 
reduce the risk of pre-eclampsia.14
China is the most populated developing country with a 
considerable incidence of adverse pregnancy outcomes, 
including maternal anaemia,15 LBW16 and small for 
gestational age (SGA).8 However, the implementation 
of FA supplementation project (take daily FA (400 µg), 
start from 3 months before pregnancy to the end of 
the first trimester) to prevent NTDs, especially in rural 
areas, is the only nutritional intervention promoted by 
the Chinese Health Ministry (now the Chinese National 
Health Commission) for pregnant women and women 
planning to be pregnant.17 18 Also, the only routine ante-
natal micronutrient supplementation recommended by 
the Chinese Nutrition Society (CNS) for women of child-
bearing age is the daily use of FA (400 µg), starting from 
3 months before the planned pregnancy until the end 
of pregnancy.19 No more guidelines for routine supple-
mentation of other micronutrients exist so that the use of 
micronutrient supplements during pregnancy varied in 
Chinese geographic areas and socioeconomic groups.4 20
All health policies and recommendations of micronu-
trient supplementation for pregnant women emphasise 
the timing, dosage, sustainability of use as well as the 
target population. Evidence showed that low compliance 
was a major reason for the low effectiveness of micronu-
trient supplementation during pregnancy8 21 and thus 
the exploration of the determinants of the adherence is 
important for guiding the appropriate use to guarantee 
the efficacy. Many factors were reported in relation to 
maternal adherence to micronutrient supplementa-
tion before and during pregnancy, including maternal 
age, educational background, occupation and antenatal 
care. Previous studies have reported on the compliance 
of maternal micronutrient supplementation in Western 
countries like the USA and Norway22 23 as well as in Africa 
countries like Ethiopia and Kenya.24 25 Few of the studies 
focused on maternal adherence to micronutrient supple-
mentation before and during pregnancy in China.
Shaanxi Province is a developing area in North-
west China where most of the micronutrients derived 
from diet among pregnant women were lower than the 
Chinese recommended nutrient intake (RNI),26 27 espe-
cially the intake of folate and calcium.26 27 Although 
dietary iron intake was close to the RNI for the first and 
second trimester, most iron from diet were the non-heme 
iron, which is not efficiently absorbed and used by the 
human body.28 Additionally, about 40% of women of 
childbearing age in the region suffered anaemia,29 and 
the incidence of adverse birth outcomes, including LBW 
and preterm birth, was high in this region.30 Therefore, 
maternal micronutrient supplementation seems to be a 
relatively inexpensive and low risk method for compen-
sating for inadequate dietary intake during pregnancy and 
improving the health status of local mothers and fetus. 
However, a representative data from a large-scale study 
on the maternal micronutrient supplementation before 
and during pregnancy in this region are not available. 
Accordingly, this article aims to investigate the condition 
of maternal micronutrient supplementation before and 
during pregnancy in Shaanxi, focusing on analysing the 
rates and associated factors of maternal adherence to 
supplement consumptions according to existing recom-
mendations and to provide evidence for future evaluation 
of health policy effectiveness and development of health 
education strategies.
MethODs
Data source and participants
The study used data from a large-scale population-based 
cross-sectional survey, which was conducted between 
August and November 2013 in the Shaanxi province 
with the purpose of investigating the prevalence and 
risk factors of birth defects among newborns, along with 
maternal dietary conditions and nutritional supplements 
use. The target population was women aged from 16 to 
49 years, who were pregnant between 2010 and 2013 and 
had specific pregnancy outcomes before the survey. The 
sample was acquired from 20 counties and 10 districts 
of Shaanxi by applying a stratified multistage random 
sampling method.27 31 First, 20 counties and 10 districts 
were randomly selected from the 80 rural counties and 24 
urban districts in Shaanxi Province according to the differ-
ence in size, distribution and fertility rates of population 
between rural and urban areas. Subsequently, in the rural 
area, 6 townships, 6 villages and 30 eligible women were 
randomly selected from each sampled county, selected 
township and selected village, respectively. In the urban 
areas, 3 streets, 6 communities and 60 eligible women 
were randomly selected from each sampled district, 
selected street and selected community, respectively. 
Data collection was completed with structured-question-
naires via in-person surveys by trained interviewers. Infor-
mation gathered included maternal sociodemographic 
characteristics, lifestyle, health condition, healthcare 
utilisation and supplement consumption. A strict quality 
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control process was used to guarantee data integrity and 
accuracy.27
A total of 30 027 women were enrolled in the survey 
after they signed the informed consent, and women with 
limited cognitive capacity had been excluded. In order to 
obtain more accurate analysis results, we further excluded 
1349 women who did not provide clear information about 
maternal nutritional supplementation (among them, 761 
women had no live birth babies in this pregnancy and 
refused to provide detailed information). In total, 28 678 
women were chosen for the final analysis.
Maternal sociodemographic characteristics, parity and 
antenatal care information
Maternal age at delivery was divided into three catego-
ries (<25, 25–34 and ≥35 years), as well as educational 
level (Junior high school or below, Senior high school 
and College and beyond), geographical area (Southern 
Shaanxi, Central Shaanxi and Northern Shaanxi) and 
per capita annual household income (Low: <8800, 
Medium: 8800–15 200 and High: ≥15 200 Yuan, where 1 
Yuan=$0.149 on 17 March 2019). Residence (urban and 
rural) and parity (primiparous and multiparous) were 
classified into two categories each. We also investigated 
the antenatal care information, including the number of 
antenatal visits (<5 and ≥5), the type of hospitals for ante-
natal visit (hospitals below the county level and county 
level hospitals or above) and pregnancy consultation (yes 
and no, referred to the participation of health counsel-
ling that related to maternal healthcare and fetal devel-
opment before or during pregnancy).
Micronutrient supplementation
Information about micronutrient supplements in tablet 
and capsule forms was mainly collected. We asked the 
participants to choose the supplements they used before 
or during pregnancy from a list of brands of supplements 
that were commonly provided in the local hospital or 
pharmacy and to further tell the brand and kind of supple-
ment they consumed, if it was not shown in the list. We did 
not list iron-FA supplements in the questionnaire, since 
few supplements on the market were two-nutrient formu-
lations of iron and FA. In the analysis, FA supplements 
referred to those that only contained FA; iron supple-
ments referred to those that only contained iron; calcium 
supplements referred to those that contained calcium 
or calcium with another micronutrient (including calci-
um-vitamin D and calcium-zinc); multiple-micronutrient 
(MMN) supplements referred to those that contained FA, 
iron and other micronutrients. Women who consumed 
any micronutrient supplement before or during preg-
nancy were considered as micronutrient supplement 
users; otherwise, they were regarded as non-users.
We further obtained the time and duration of use of 
each supplement they reported. The participants were 
required to select the time of supplement use from the four 
pregnancy periods (3 months before the last menstrual 
period, the first trimester, the second trimester and the 
third trimester) and report the duration of supplementa-
tion for each supplement they used. The 3 months before 
the last menstrual period was defined as the preconcep-
tional period; the time from the 3 months before the last 
menstrual period to the end of ﬁrst trimester was defined 
as the periconceptional period; the time of the second 
and third trimester was defined as the after-periconcep-
tional period.
Adherence to micronutrient supplementation before 
and during pregnancy was determined by the start time 
and duration of use according to Chinese guidelines (for 
FA) and WHO recommendations (for iron, calcium and 
MMN). Although WHO did not universally recommend 
MMN supplementation (MMS) for pregnant women, due 
to its components of iron and FA, we still examined the 
compliance of MMS by referencing the WHO recommen-
dation for iron and FA supplementation. We considered 
the duration of use instead of the total amounts, because 
most of the supplements of interest were taken as one 
tablet daily. In the present study, the thresholds used to 
define the adhered duration of use were 180 days for FA 
and 90 days for others. Therefore, high adherence to FA 
supplementation was defined as starting from the peri-
conceptional period with ≥180 days of use; otherwise, it 
was regarded as low adherence. High adherence to iron 
supplementation was considered as starting from the first 
trimester with ≥90 days of use; otherwise, it was regarded 
as low adherence. For calcium supplementation, 20 weeks 
of gestation was the start time recommended by WHO. 
Since we did not collect the specific weeks of gestation 
of micronutrient supplementation, high adherence to 
calcium supplementation was considered as starting from 
the second trimester with ≥90 days of use; otherwise, 
it was regarded as low adherence. High adherence to 
MMS was defined as one starting from the first trimester 
with ≥90 days of use; otherwise, it was considered as low 
adherence.
statistical analysis
Dataset was established using Epidata 3.1 (The Epidata 
Association, Odense, Denmark) with double entry. 
Multiple imputation was used to attribute values for 
the missing variables, including income level (n=5830), 
maternal age group (n=434) and the type of hospital 
for antenatal visits (n=327), taking education level, 
geographic area, residence, parity, the number of ante-
natal visits and pregnancy consultation as covariates 
with five imputed data sets.32 Numbers and percentages 
(n (%)) were estimated for reporting the rate of micro-
nutrient supplementation in different groups and for 
presenting the adherence to micronutrient supplemen-
tation. Comparisons between groups were completed by 
either the χ² test or Fisher's exact test.
Because of the hierarchical structure of the data derived 
from the stratified multistage random sampling design, 
multivariable generalised estimating equation (GEE) 
models33 with random effect at county level were applied 
to estimate adjusted OR and 95% CI for factors associated 
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with maternal adherence to micronutrient supplementa-
tion before and during pregnancy. Maternal characteris-
tics including age, education, residence, income, parity, 
pregnancy consultation, number of antenatal visits and 
type of hospital for antenatal visits were the fixed effects 
in the GEE models. Binomial distribution, logit link func-
tion and an exchangeable covariance structure were used 
in the GEE analysis. Model 1 analysed the relationship 
between the adherence to micronutrient supplementa-
tion and the sociodemographic characteristics including 
age, education, residence and income. Model 2 analysed 
the relationship between the adherence to micronutrient 
supplementation and sociodemographic characteristics 
(all the variables in model 1), as well as parity and ante-
natal care characteristics. The criteria for statistical signif-
icance was p<0.05. All analyses were performed using SAS 
V.9.4 (SAS Institute, Cary, North Carolina, USA).
results
Maternal characteristics according to micronutrient 
supplementation before and during pregnancy
Significant differences existed in aspects of maternal 
sociodemographic conditions, birth history and ante-
natal care characteristics between users and non-users of 
micronutrient supplements before and during pregnancy 
(table 1). Users of micronutrient supplements were more 
likely to be aged from 25 to 34 years, be better educated, 
have higher income level, live in central Shaanxi, be rural 
residents, be primiparous and have better antenatal care 
(including pregnancy consultations, higher-level hospital 
for antenatal visits and a higher frequency of antenatal 
visits).
rates of and the adherence to micronutrient supplementation 
before and during pregnancy
In total, 83.9% of women took at least one kind of micro-
nutrient supplement before or during their last preg-
nancy. The main supplements used by participants were 
FA (67.6%), calcium (57.5%), MMN (14.0%) and iron 
(5.4%) (table 2). Although FA had a relatively higher rate 
of use during the periconceptional period (64.5%), only 
7.4% of women continued usage from the periconcep-
tional period for longer than 180 days. Most of the users 
started taking calcium supplements during the second 
trimester (39%), but only 11.7% met the recommended 
standards after taking the duration of use into consider-
ation. Comparing with the rates of those who began to 
use iron or MMN in the after-periconceptional period 
(3.7% for iron and 8.2% for MMN), smaller proportion 
of women started consumption from the first trimester 
(1.7% for iron and 5.8% for MMN) and few of them 
adhered to use of iron or MMN in more than 90 days 
(0.6% for iron and 2.7% for MMN) (table 3). We also 
found that very few women (0.2%) consumed FA and iron 
starting from the first trimester with more than 90 days of 
use (not shown in table). We further examined the adher-
ence to supplementation of FA, iron and FA with iron by 
taking the contribution of MMS into consideration. Still, 
the rates of compliant use were low (8.5% for FA, 3.2% 
for iron and 2.9% for FA with iron, not shown in table).
Factors associated with the adherence to micronutrient 
supplementation before and during pregnancy
Table 4 shows the results of multivariable GEE models. 
Higher educational levels (eg, FA: Senior high school 
vs Junior high school or below: OR 1.38, 95% CI 1.18 to 
1.61; College and beyond vs Junior high school or below: 
OR 2.59, 95% CI 2.21 to 3.05), higher income levels (eg, 
FA: High vs Low: OR 1.27, 95% CI 1.11 to 1.45), urban 
residence (eg, FA: Urban vs Rural: OR 1.72, 95% CI 1.08 
to 2.72) and better antenatal care (including pregnancy 
consultation (eg, FA: Yes vs No: OR 1.91, 95% CI 1.71 to 
2.14) and a higher frequency of antenatal visits (eg, FA: 
≥5 times vs <5 times: OR 1.59, 95% CI 1.35 to 1.87)) were 
associated with high adherence to micronutrient supple-
mentation before and during pregnancy. Compared with 
women below 25 years, women aged from 25 to 34 years 
were more likely to have high adherence to the supple-
mentation of FA (OR 1.30, 95% CI 1.11 to 1.52), iron (OR 
1.49, 95% CI 1.18 to 1.88) and MMN (OR 1.38, 95% CI 
1.12 to 1.71). Women above 35 years were associated 
with a lower probability of high adherence to calcium 
supplementation (OR 0.71, 95% CI 0.62 to 0.81). Being 
multipara was less likely related to high adherence to FA 
supplementation (OR 0.70, 95% CI 0.58 to 0.84). The 
type of hospital for antenatal visits was not linked to the 
adherence to micronutrient supplementation.
DIsCussIOn
In this large-scale cross-sectional study, we observed that 
micronutrient supplements were not used as commonly 
as expected before and during pregnancy, and maternal 
adherence to micronutrient supplementation among our 
population, particularly in women with sociodemograph-
ic-disadvantages, was low based on the CNS and WHO 
recommendations. Totally, the prevalence of maternal 
micronutrient supplementation before and during preg-
nancy in Shaanxi from 2010 to 2013 was 83.9%. Compared 
with other countries, our overall use rate was higher than 
that of USA from 1999 to 2006 (77.6%),2 but lower than 
those of Sydney, Australia in 2014 (93.8%)34 and Seoul, 
Korea in 2012 (88%).35 Compared with the domestic 
data, it was similar to that of Sichuan Province (81.8%) 
in 20104 and higher than the overall prevalence of eight 
Provinces of China in 2009 (66.4%).20 FA, calcium, MMN 
and iron were the four supplements primarily used by 
participants.
Maternal FA supplementation is associated with the 
prevention of NTDs as well as the reduced risk of preterm 
delivery and SGA births.36 Both WHO and CNS devel-
oped guidelines for promoting daily FA supplementa-
tion before and during pregnancy,13 19 and the Chinese 
government also implemented the periconceptional FA 
supplementation to prevent NTDs since 2009. In our 
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Table 1 Maternal characteristics according to micronutrient supplementation before and during pregnancy among Chinese 
women in Shaanxi, 2010–2013
Characteristics
Micronutrient supplementation
Yes
(n=24 051)
No
(n=4627)
P value*n % n %
Sociodemographic characteristics
Age (years) <0.001
  <25 7843 32.6 1615 34.9
  25–34 14 299 59.5 2465 53.3
  ≥35 1909 7.9 547 11.8
Education <0.001
  Junior high school or below 14 113 58.7 3611 78.0
  Senior high school 5114 21.3 627 13.6
  College and beyond 4824 20.0 389 8.4
Geographic area <0.001
  Southern Shaanxi 5099 21.2 776 16.8
  Central Shaanxi 13 731 57.1 1725 37.3
  Northern Shaanxi 5221 21.7 2126 45.9
Residence <0.001
  Rural 15 846 65.9 3455 74.7
  Urban 8205 34.1 1172 25.3
Per capita annual household income (RMB) <0.001
  Low 7990 33.2 1714 37.0
  Medium 7819 32.5 1604 34.7
  High 8242 34.3 1309 28.3
Birth history and antenatal care information
Parity <0.001
  Primiparous 14 651 60.9 2152 46.5
  Multiparous 9400 39.1 2475 53.5
Pregnancy consultation† <0.001
  No 17 404 72.4 3981 86.0
  Yes 6647 27.6 646 14.0
The number of antenatal visits <0.001
  <5 6310 26.2 2298 49.7
  ≥5 17 741 73.8 2329 50.3
Type of hospitals for antenatal visits <0.001
  Township hospitals 2783 11.6 622 13.4
  County hospitals or above 21 268 88.4 4005 86.6
*P values for the differences among groups were derived from either the χ2 tests or Fisher's exact test.
†Referred to the participation of health counselling that related to maternal healthcare and fetal development before or during pregnancy.
population, FA was the most popularly used supple-
ment before and during pregnancy, but more than 30% 
of women still did not take it. Additionally, most of the 
users started to take FA supplements after they became 
pregnant and only few took FA supplements to prepare 
for pregnancy, which may indicate the high frequency of 
unplanned pregnancies or the lack of knowledge about 
preconceptional FA supplementation. The more serious 
reality was that less than 10% of women adhered to FA 
supplementation periconceptionally in more than 180 
days. Therefore, the use of FA supplements failed to reach 
the recommended standards among pregnant women in 
Northwest China, even when maternal routine FA supple-
mentation was strongly promoted in China.
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Table 2 Rates of maternal micronutrient supplementation 
before and during pregnancy among Chinese women in 
Shaanxi, 2010–2013
Micronutrient supplements n %
Folic acid 19 352 67.6
Calcium 16 414 57.5
Multiple micronutrient 4018 14.0
Iron 1547 5.4
Vitamin C 1147 4.0
B Vitamins 814 2.8
Vitamin E 173 0.6
Others* 1271 4.4
*Including vitamin A, vitamin D and fish oil.
China has a high prevalence of pregnancy anaemia, 
which is commonly caused by iron deficiency during preg-
nancy.15 37 Reviews stated that daily iron supplementation 
in pregnancy could be useful in improving iron status 
and birth outcomes.6 38 Only 5.4% of the participants 
consumed iron supplements during pregnancy, and the 
low rate of iron supplementation was possibly attributed 
to the lack of routine maternal iron supplementation 
guidelines in China and the popular use of antianaemic 
Chinese patent medicines among pregnant women in this 
region.39 The proportion of women who had compliant 
iron supplementation was very low in our population 
(0.6% for iron and 3.2% for iron and iron-containing 
MMS), which is much lower than that of Western Amhara 
of Ethiopia (20.4% for FA-iron).21 On the basis of the 
WHO recommendation, maternal iron supplementation 
should be started as early as possible during pregnancy.13 
Our participants usually began to use iron supplements 
after the periconceptional period rather than from the 
beginning of pregnancy. The reason may be that most 
women only took iron supplements under the direction 
of physicians after the occurrence of iron deficiency or 
iron deficiency anaemia during the second half of preg-
nancy, but prophylactic supplementation was very rare.
Maternal calcium supplementation has a clear benefi-
cial effect on hypertension-related disorders during preg-
nancy and is possibly related to the reduction of preterm 
birth risk.40 To prevent pre-eclampsia, WHO recommends 
daily calcium supplementation from 20 weeks of gestation 
for populations with low dietary calcium intake.14 From 
the background of the low dietary calcium intake among 
pregnant women (512 mg/d)27 and the high prevalence 
of preterm birth,41 the WHO guideline may be suitable 
for widespread implementation in our population. A gap 
still exists between calcium supplementation among preg-
nant women in Northwest China and the WHO recom-
mendation, according to the fact that more than 40% of 
women did not take calcium supplements during preg-
nancy and only 11.7% of the participants adhered to take 
calcium right from the start of the second trimester for 
more than 90 days of use.
Evidence demonstrated that periconceptional MMS 
with iron and FA could promote maternal health status, 
reduce the risk of LBW, SGA and congenital abnormali-
ties42 43 as well as improve the long-term intellectual devel-
opment of offspring.44 Developed countries like Australia 
had a high prevalence of periconceptional MMS (79.2%),34 
but the rate of MMS among our participants was 14.0%. 
WHO did not universally recommend MMS for pregnant 
women due to its potential neonatal mortality risks,11 but 
the recent evidence showed no increased risk of neonatal 
mortality.43 45 Moreover, the 2016 WHO guidelines stated 
that ‘policy-makers in populations with a high prevalence 
of nutritional deficiencies might consider the benefits of 
MMS on maternal health to outweigh the disadvantages 
and may choose to give MMS that include iron and folic 
acid’. Comprehensively taking the situations of Shaanxi 
(including high incidence of adverse birth outcomes, low 
intake of most micronutrients from daily diet as well as 
from supplements and disadvantaged sociodemographic 
conditions among many pregnant women) into consid-
eration, to replace iron and FA with MMS for pregnant 
women in low-income areas might be a useful strategy 
to improve overall maternal micronutrient intake in this 
region.43
When examining the factors associated with maternal 
adherence to micronutrient supplementation before 
and during pregnancy, we found that sociodemographic 
disadvantages and lower antenatal care level were associ-
ated with low adherence to micronutrient supplementa-
tion. Similar associations between educational level and 
prenatal health counselling with adherence to micronu-
trient supplementation were reported in literature.10 24 46 
Our finding that higher age and primiparity were predic-
tors of compliant use of FA was consistent with that of 
a previous study in Ireland.47 We did not find any rela-
tionship between the type of hospital for antenatal visits 
and FA supplementation, which may reflect the balanced 
implementation of national health policy on maternal FA 
supplementation in the health system of the study region. 
In our population, higher frequency of antenatal visits 
was associated with higher adherence to micronutrient 
supplementation. Aside from routine obstetric examina-
tion, women accept the phased health education from the 
physicians during their antenatal care visits. In addition, 
women planning to be pregnant or are pregnant (before 
12 weeks of gestation) can receive free FA provided by 
the Chinese government during antenatal care visits 
and learn to appropriately use them under professional 
guidance. Iron or calcium supplementation is usually 
recommended to pregnant women by physicians after 
the diagnosis of physical or pathological changes related 
to iron or calcium deficiency. For women with severe 
pregnancy reactions or MMN deficiency, the physician 
may recommend MMS. Thus, higher frequency of ante-
natal care visits provides more opportunities for women 
to learn and increases the possibilities for physicians to 
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Table 3 Maternal micronutrient supplementation recommendations from WHO and CNS; rates of main micronutrient 
supplementation by start time and duration of use and adherence to micronutrient supplementation before and during 
pregnancy among Chinese women in Shaanxi, 2010–2013
FA
(n=28 629)
Iron
(n=28 644)
Calcium
(n=28 548)
MMN
(n=28 628)
Recommendations
WHO recommendation 1.Purpose: NTDs prevention
Settings: all
Supplementation: daily use of FA 
(400 µg)
Duration: start at 2 months before 
the planned pregnancy until 12 
weeks of pregnancy
2.See recommendation for iron 
and FA supplementation in the 
right column
Purpose: pregnancy 
outcome improvement
Settings: all
Supplementation: daily 
use of iron (30–60 mg)-FA 
(400 µg)
Duration: throughout 
pregnancy
Purpose: pre-
eclampsia prevention
Settings: areas with 
low calcium intake
Supplementation: 
daily use of calcium 
(1.5–2.0 g)
Duration: from 20 
weeks’ gestation until 
the end of pregnancy
N/A
CNS recommendation Purpose: NTDs prevention and 
pregnancy outcome improvement
Settings: all regions in China
Supplementation: daily use of FA 
(400 µg)
Duration: start at 3 months before 
the planned pregnancy until the 
end of pregnancy
No routine iron 
supplementation is 
recommended for 
pregnant women;
Pregnant women with 
severe anaemia should 
appropriately take iron 
supplements under the 
guidance of physicians
N/A N/A
Micronutrient supplementation in our population (n (%))
Start at periconceptional period 18 469 (64.5) 499 (1.7) 5292 (18.5) 1665 (5.8)
  Start at 3 month before 
pregnancy
4966 (17.4) 79 (0.3) 272 (1.0) 212 (0.8)
   <90 days (180 days for FA) 3373 (11.8) 35 (0.1) 104 (0.4) 81 (0.3)
   ≥90 days (180 days for FA) 1593 (5.6) 44 (0.2) 168 (0.6) 131 (0.5)
  Start at first trimester 13 503 (47.2) 420 (1.5) 5020 (17.6) 1453 (5.1)
   <90 days (180 days for FA) 12 992 (45.4) 243 (0.9) 2291 (8.0) 683 (2.4)
   ≥90 days (180 days for FA) 511 (1.8) 177 (0.6) 2729 (9.6) 770 (2.7)
Start at after-periconceptional 
period
883 (3.1) 1048 (3.7) 11 122 (39.0) 2353 (8.2)
  Start at second trimester 737 (2.6) 633 (2.2) 8947 (31.4) 1844 (6.4)
   <90 days 524 (1.8) 454 (1.6) 5614 (19.7) 1238 (4.3)
   ≥90 days 213 (0.7) 179 (0.6) 3333 (11.7) 606 (2.1)
  Start at third trimester 146 (0.5) 415 (1.5) 2175 (7.6) 508 (1.8)
   <90 days 127 (0.4) 365 (1.3) 1810 (6.3) 435 (1.5)
   ≥90 days 19 (0.1) 50 (0.2) 365 (1.3) 73 (0.3)
Adherence to micronutrient supplementation (n (%))*
  Low adherence 26 525 (92.7) 28 467 (99.4) 25 215 (88.3) 27 858 
(97.3)
  High adherence 2104 (7.4) 177 (0.6) 3333 (11.7) 770 (2.7)
*High adherence to FA supplementation was defined as starting from the periconceptional period with ≥180 days of use; otherwise, it 
was regarded as low adherence. High adherence to iron supplementation was considered as starting from the first trimester with ≥90 
days of use; otherwise, it was regarded as low adherence. High adherence to calcium supplementation was considered as starting 
from the second trimester with ≥90 days of use; otherwise, it was regarded as low adherence. High adherence to MMS was defined as 
starting from the first trimester with ≥90 days of use; otherwise, it was considered as low adherence.
FA, folic acid; MMN, multiple-micronutrients; CNS, Chinese Nutrition Society.
know the pregnant women’s health condition and to give 
recommendations in time, which finally promotes the 
adherence to micronutrient supplementation.
To the best of our knowledge, this is the first large-scale 
and representative study that investigated maternal micro-
nutrient supplementation before and during pregnancy 
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in Northwest China. To guarantee the representativeness, 
a large sample was recruited from Shaanxi Province of 
Northwest China using a stratified multistage random 
sampling method according to the proportion of rural to 
urban residents, population size and fertility rate in the 
region. The results could be generalised to other regions 
in Northwest China according to the similarities in terms 
of economy, culture, lifestyle and diet habits existing in 
these regions and may also reflect the universality of the 
low adherence to micronutrient supplementation before 
and during pregnancy in China. Therefore, it could serve 
as a basis for developing health education strategies in the 
future. Nonetheless, several limitations of the present study 
should be stated. First, this study was retrospective and all 
the information of micronutrient supplementation was 
self-reported from participants and therefore recall bias 
was ineluctable. Second, we did not provide an insight into 
the dosage of use. Although we listed the possible brands 
of supplements that women might consume, many women 
could only recall the micronutrient they used without 
clear commodity information. Except for FA supplements, 
which usually have specified dosage of 400 µg per pill, the 
specifications of other supplements vary from each other 
and thus it is difficult to calculate the accurate dosage used 
by our participants. However, what is certain is that some 
supplements women consumed were not specialised for 
pregnant women and thus the content of elemental iron 
or calcium in one tablet of the supplement is lower than 
the WHO recommended dosage, which may indicate the 
more severe situation of low adherence of micronutrient 
supplementation in our population. Third, the sources 
of recommendation regarding the use of supplements, 
as well as the access that women procured the supple-
ments, were not recorded. Hence, the approach for more 
appropriate future interventions could not be known. 
More large-scale, in-depth and well-designed studies are 
recommended to explore the effectiveness of supplemen-
tation of iron, calcium and MMN on pregnancy outcomes 
according to the adherence of use and further promote 
the establishment of new nutritional recommendations 
for pregnancy in China.
COnClusIOn
In conclusion, maternal micronutrient supplementation 
before and during pregnancy in Shaanxi failed to meet 
the Chinese guidelines and WHO recommendation, with 
respect to start time and duration of use. Improving the 
adherence to micronutrient supplementation before or 
during pregnancy is still a dire issue for maternal and 
child health in Northwest China. Targeted health educa-
tion and future guidelines of micronutrient supplemen-
tation for pregnant women should be implemented, 
especially for those with disadvantaged sociodemographic 
conditions.
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